Collaboration partners and funding sources

Furtner J, Berchtold L, Le Rhun E, Silvani A, Rudà R, Lombardi G, Sepúlveda-Sánchez JM, Brandal P, Bendszus M, Golfinopoulos V, Gorlia T, Sahm F, Wick W, Minniti G, Weller M, König F, Preusser M (2025)
Prognostic value of 1D, 2D, and volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas: Radiological post-hoc analysis of the EORTC-BTG-1320 trial
Neurooncol Adv, 7 (1), vdaf152
DOI 10.1093/noajnl/vdaf152, PubMed 40735273

Gjelsvik YM, Myklebust TÅ, Fosså SD, Haug ES, Kvåle R, Ursin G, Johannesen TB (2025)
A nationwide, longitudinal collection of patient-reported outcomes from prostate cancer patients and controls
Qual Life Res (in press)
DOI 10.1007/s11136-025-04017-7, PubMed 40603678

Harba D, Corell A, Mansouri A, Brandal P, Blomstrand M, Jakola AS (2025)
A scoping review of proton radiation therapy and mutant-isocitrate dehydrogenase-inhibitors in IDH mutated lower-grade gliomas: pushing beyond surrogate end-points
Acta Neurochir (Wien), 167 (1), 196
DOI 10.1007/s00701-025-06612-6, PubMed 40682696